 | • レポートコード：MRC2012B1471 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ウィルソン病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ウィルソン病治療の種類別市場規模（D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Valeant Pharmaceuticals International. Inc.、Kadmon Holding, Inc.、VHB Life Science Inc.、Tsumura & Co、Noble Pharma Co., Ltd、Merck & Co、Wilson's Therapeutics AB、Teva Pharmaceuticals USA, Inc、 ・地域別グローバル市場分析 2015年-2020年 ・ウィルソン病治療の北米市場（アメリカ、カナダ、メキシコ） ・ウィルソン病治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ウィルソン病治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ウィルソン病治療の南米市場（ブラジル、アルゼンチン） ・ウィルソン病治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：D-ペニシラミン、トリエンチン、テトラチオモリブデート、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Wilson’s Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Wilson’s Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Wilson’s Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Wilson’s Disease Treatment market has been segmented into:
D-Penicillamine
Trientine
Tetrathiomolybdate
Others
By Application, Wilson’s Disease Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Wilson’s Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Wilson’s Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Wilson’s Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Wilson’s Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Wilson’s Disease Treatment Market Share Analysis
Wilson’s Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Wilson’s Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Wilson’s Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Wilson’s Disease Treatment are:
Valeant Pharmaceuticals International. Inc.
Kadmon Holding, Inc.
VHB Life Science Inc.
Tsumura & Co
Noble Pharma Co., Ltd
Merck & Co
Wilson’s Therapeutics AB
Teva Pharmaceuticals USA, Inc
Table of Contents
1 Wilson’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Wilson’s Disease Treatment
1.2 Classification of Wilson’s Disease Treatment by Type
1.2.1 Global Wilson’s Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Wilson’s Disease Treatment Revenue Market Share by Type in 2019
1.2.3 D-Penicillamine
1.2.4 Trientine
1.2.5 Tetrathiomolybdate
1.2.6 Others
1.3 Global Wilson’s Disease Treatment Market by Application
1.3.1 Overview: Global Wilson’s Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Wilson’s Disease Treatment Market by Regions
1.4.1 Global Wilson’s Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Wilson’s Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Wilson’s Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Wilson’s Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Wilson’s Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Wilson’s Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Wilson’s Disease Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Valeant Pharmaceuticals International. Inc.
2.1.1 Valeant Pharmaceuticals International. Inc. Details
2.1.2 Valeant Pharmaceuticals International. Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Valeant Pharmaceuticals International. Inc. SWOT Analysis
2.1.4 Valeant Pharmaceuticals International. Inc. Product and Services
2.1.5 Valeant Pharmaceuticals International. Inc. Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kadmon Holding, Inc.
2.2.1 Kadmon Holding, Inc. Details
2.2.2 Kadmon Holding, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kadmon Holding, Inc. SWOT Analysis
2.2.4 Kadmon Holding, Inc. Product and Services
2.2.5 Kadmon Holding, Inc. Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 VHB Life Science Inc.
2.3.1 VHB Life Science Inc. Details
2.3.2 VHB Life Science Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 VHB Life Science Inc. SWOT Analysis
2.3.4 VHB Life Science Inc. Product and Services
2.3.5 VHB Life Science Inc. Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Tsumura & Co
2.4.1 Tsumura & Co Details
2.4.2 Tsumura & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Tsumura & Co SWOT Analysis
2.4.4 Tsumura & Co Product and Services
2.4.5 Tsumura & Co Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Noble Pharma Co., Ltd
2.5.1 Noble Pharma Co., Ltd Details
2.5.2 Noble Pharma Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Noble Pharma Co., Ltd SWOT Analysis
2.5.4 Noble Pharma Co., Ltd Product and Services
2.5.5 Noble Pharma Co., Ltd Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co
2.6.1 Merck & Co Details
2.6.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co SWOT Analysis
2.6.4 Merck & Co Product and Services
2.6.5 Merck & Co Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Wilson’s Therapeutics AB
2.7.1 Wilson’s Therapeutics AB Details
2.7.2 Wilson’s Therapeutics AB Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Wilson’s Therapeutics AB SWOT Analysis
2.7.4 Wilson’s Therapeutics AB Product and Services
2.7.5 Wilson’s Therapeutics AB Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceuticals USA, Inc
2.8.1 Teva Pharmaceuticals USA, Inc Details
2.8.2 Teva Pharmaceuticals USA, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceuticals USA, Inc SWOT Analysis
2.8.4 Teva Pharmaceuticals USA, Inc Product and Services
2.8.5 Teva Pharmaceuticals USA, Inc Wilson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Wilson’s Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Wilson’s Disease Treatment Players Market Share
3.2.2 Top 10 Wilson’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Wilson’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America Wilson’s Disease Treatment Revenue by Countries
5.1 North America Wilson’s Disease Treatment Revenue by Countries (2015-2020)
5.2 USA Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe Wilson’s Disease Treatment Revenue by Countries
6.1 Europe Wilson’s Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Wilson’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Wilson’s Disease Treatment Revenue by Countries (2015-2020)
7.2 China Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America Wilson’s Disease Treatment Revenue by Countries
8.1 South America Wilson’s Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Wilson’s Disease Treatment by Countries
9.1 Middle East & Africa Wilson’s Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Wilson’s Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Wilson’s Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Wilson’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 D-Penicillamine Revenue Growth Rate (2015-2025)
10.4 Trientine Revenue Growth Rate (2015-2025)
10.5 Tetrathiomolybdate Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Wilson’s Disease Treatment Market Segment by Application
11.1 Global Wilson’s Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 Wilson’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Wilson’s Disease Treatment Market Size Forecast (2021-2025)
12.1 Global Wilson’s Disease Treatment Market Size Forecast (2021-2025)
12.2 Global Wilson’s Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America Wilson’s Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Wilson’s Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Wilson’s Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America Wilson’s Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Wilson’s Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Wilson's Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Wilson's Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Wilson's Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Wilson's Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Valeant Pharmaceuticals International. Inc. Corporate Information, Location and Competitors
Table 6. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Major Business
Table 7. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Valeant Pharmaceuticals International. Inc. SWOT Analysis
Table 9. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Product and Solutions
Table 10. Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kadmon Holding, Inc. Corporate Information, Location and Competitors
Table 12. Kadmon Holding, Inc. Wilson's Disease Treatment Major Business
Table 13. Kadmon Holding, Inc. Wilson's Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Kadmon Holding, Inc. SWOT Analysis
Table 15. Kadmon Holding, Inc. Wilson's Disease Treatment Product and Solutions
Table 16. Kadmon Holding, Inc. Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. VHB Life Science Inc. Corporate Information, Location and Competitors
Table 18. VHB Life Science Inc. Wilson's Disease Treatment Major Business
Table 19. VHB Life Science Inc. Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 20. VHB Life Science Inc. SWOT Analysis
Table 21. VHB Life Science Inc. Wilson's Disease Treatment Product and Solutions
Table 22. VHB Life Science Inc. Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Tsumura & Co Corporate Information, Location and Competitors
Table 24. Tsumura & Co Wilson's Disease Treatment Major Business
Table 25. Tsumura & Co Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Tsumura & Co SWOT Analysis
Table 27. Tsumura & Co Wilson's Disease Treatment Product and Solutions
Table 28. Tsumura & Co Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Noble Pharma Co., Ltd Corporate Information, Location and Competitors
Table 30. Noble Pharma Co., Ltd Wilson's Disease Treatment Major Business
Table 31. Noble Pharma Co., Ltd Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Noble Pharma Co., Ltd SWOT Analysis
Table 33. Noble Pharma Co., Ltd Wilson's Disease Treatment Product and Solutions
Table 34. Noble Pharma Co., Ltd Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck & Co Corporate Information, Location and Competitors
Table 36. Merck & Co Wilson's Disease Treatment Major Business
Table 37. Merck & Co Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Merck & Co SWOT Analysis
Table 39. Merck & Co Wilson's Disease Treatment Product and Solutions
Table 40. Merck & Co Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Wilson's Therapeutics AB Corporate Information, Location and Competitors
Table 42. Wilson's Therapeutics AB Wilson's Disease Treatment Major Business
Table 43. Wilson's Therapeutics AB Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Wilson's Therapeutics AB SWOT Analysis
Table 45. Wilson's Therapeutics AB Wilson's Disease Treatment Product and Solutions
Table 46. Wilson's Therapeutics AB Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Teva Pharmaceuticals USA, Inc Corporate Information, Location and Competitors
Table 48. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Major Business
Table 49. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Teva Pharmaceuticals USA, Inc SWOT Analysis
Table 51. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Product and Solutions
Table 52. Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Wilson's Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Wilson's Disease Treatment Revenue Share by Players (2015-2020)
Table 55. Global Wilson's Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Wilson's Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Wilson's Disease Treatment Revenue by Countries (2015-2020)
Table 58. North America Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Wilson's Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Wilson's Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Wilson's Disease Treatment Revenue by Countries (2015-2020)
Table 62. South America Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Wilson's Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Wilson's Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Wilson's Disease Treatment Revenue Share by Type (2015-2020)
Table 67. Global Wilson's Disease Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Wilson's Disease Treatment Revenue by Application (2015-2020)
Table 69. Global Wilson's Disease Treatment Revenue Share by Application (2015-2020)
Table 70. Global Wilson's Disease Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Wilson's Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Wilson's Disease Treatment Picture
Figure 2. Global Wilson's Disease Treatment Revenue Market Share by Type in 2019
Figure 3. D-Penicillamine Picture
Figure 4. Trientine Picture
Figure 5. Tetrathiomolybdate Picture
Figure 6. Others Picture
Figure 7. Wilson's Disease Treatment Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Wilson's Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Wilson's Disease Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Wilson's Disease Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Wilson's Disease Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Wilson's Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Wilson's Disease Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Wilson's Disease Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Wilson's Disease Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Wilson's Disease Treatment Revenue Market Share by Countries in 2019
Figure 44. China Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Wilson's Disease Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Wilson's Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Wilson's Disease Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Wilson's Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Wilson's Disease Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Wilson's Disease Treatment Revenue Share by Type in 2019
Figure 61. Global Wilson's Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global D-Penicillamine Revenue Growth Rate (2015-2020)
Figure 63. Global Trientine Revenue Growth Rate (2015-2020)
Figure 64. Global Tetrathiomolybdate Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Wilson's Disease Treatment Revenue Share by Application (2015-2020)
Figure 67. Global Wilson's Disease Treatment Revenue Share by Application in 2019
Figure 68. Global Wilson's Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Clinic Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Wilson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Wilson's Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Wilson's Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Wilson's Disease Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Wilson's Disease Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Wilson's Disease Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Wilson's Disease Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Wilson's Disease Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
ウィルソン病治療の世界市場（～2026年） Market Analysis and Insights: Global Wilson's Disease Treatment Market The global Wilson's Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wilson's Disease Treatment Scope and Market Size Wilson's Dis…- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…